Formulation optimization of controlled-release pellets of metoclopramide hydrochloride using dissolution fit factor approach

被引:1
|
作者
Wang, MT
Tsai, FH
Wang, DP [1 ]
机构
[1] Natl Def Med Ctr, Sch Pharm, Taipei, Taiwan
[2] Tri Serv Gen Hosp, Dept Pharm, Taipei, Taiwan
关键词
D O I
10.1081/DDC-100101272
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The purpose of this study was to optimize the formulation variables for the preparation of ethyl cellulose-coated nonpareils loaded with metoclopramide hydrochloride (MCL). The approach to evaluate the effectiveness of formulation parameters was monitored by release rate resting using dissolution fit factors as a tool. The content of ethyl cellulose used in the formulation was based on the drug-loaded weight. The interrelationship of each developed formulation and the reference formulation Gastro-Timelets(R) and their respective dissolution curves were evaluated using Moore's equation: f(2) = 50 X log {[1 + 1/n Sigma(t=1)(n) Wt(Rt - Tt)(2)](-0.5) X 100} The relationship between the ethyl cellulose content in the formulation and the dissolution fit factor f2 can be described as the following regression equation: Y = -0.054X(2) + 3.347X - 1.915 (r(2) = 0.99). The optimum ethyl cellulose content obtained from the equation was 30.8%. The type and content of plasticizer used in the formulation to achieve the greatest f(2) were determined to be Myvacet 9-40 at the concentration of 25%. Results indicated that using the release rare testing approach with the dissolution fit factor as a tool could provide valuable information for formulation optimization.
引用
收藏
页码:577 / 581
页数:5
相关论文
共 50 条
  • [41] Controlled-release behavior of diphenhydramine hydrochloride loaded neutral microgranules and coated using ethylcellulose water dispersion
    Opota, DO
    Joachim, G
    Kalantzis, G
    Piccerelle, P
    Reynier, JP
    Joachim, J
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1999, 25 (01) : 81 - 87
  • [42] FORMULATION DESIGN OF EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE EXTENDED RELEASE TABLETS: OPTIMIZATION OF FORMULATION USING STATISTICAL EXPERIMENTAL DESIGN
    Chinta, Rajarao
    Pilli, Rohini
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2020, 11 (12): : 6434 - 6447
  • [43] DEVELOPMENT OF DICLOFENAC SODIUM CONTROLLED-RELEASE SOLID DISPERSIONS BY SPRAY-DRYING USING OPTIMIZATION STRATEGY .1. POWDER FORMULATION
    DANGPRASIRT, P
    RITTHIDEJ, GC
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1995, 21 (20) : 2323 - 2337
  • [44] COMPUTER OPTIMIZATION FOR THE FORMULATION OF CONTROLLED-RELEASE THEOPHYLLINE TABLET MADE OF MICRONIZED LOW-SUBSTITUTED HYDROXYPROPYLCELLULOSE AND METHYLCELLULOSE
    MATSUMURA, M
    NAKAGAMI, H
    YAMAO, T
    TAKAYAMA, K
    NAGAI, T
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1994, 42 (09) : 1902 - 1908
  • [45] Preparation and characterization of controlled-release doxazosin mesylate pellets using a simple drug layering-aquacoating technique
    Hazzah H.A.
    EL-Massik M.A.
    Abdallah O.Y.
    Abdelkader H.
    Journal of Pharmaceutical Investigation, 2013, 43 (4) : 333 - 342
  • [46] FORMULATION, EVALUATION AND VALIDATION OF SWELLABLE CONTROLLED RELEASE SYSTEMS OF METFORMIN HYDROCHLORIDE USING NATURAL POLYMERS
    Shivhare, U. D.
    Bhusari, K. P.
    Awari, J. G.
    ASIAN JOURNAL OF PHARMACEUTICS, 2007, 1 (01) : 100 - 107
  • [47] The plasma concentration-time profile of beta-alanine using a controlled-release formulation (Carnosyn®)
    Harris, Roger C.
    Jones, Glenys
    Wise, John A.
    FASEB JOURNAL, 2008, 22
  • [48] Development of a flow through dissolution method for the determination of metformin hydrochloride and comparison of an in-house versus commercial controlled release formulation
    Li, C. L.
    Martini, L. G.
    Lee, C. P.
    Taylor, J.
    Evans, S.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2004, 56 : S37 - S37
  • [49] Formulation and optimization of controlled release powder for reconstitution for metoprolol succinate multi unit particulate formulation using risk based QbD approach
    Mundada, Piyush K.
    Sawane, Krutika K.
    Mundada, Veenu P.
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2017, 41 : 462 - 474
  • [50] Once Daily, High-Dose Mesalazine Controlled-Release Tablet for Colonic Delivery: Optimization of Formulation Variables Using Box–Behnken Design
    Ahmed Abd Elbary
    Ahmed A. Aboelwafa
    Ibrahim M. Al Sharabi
    AAPS PharmSciTech, 2011, 12 : 1454 - 1464